Radiology Doctors in Port Matilda, PA Accepting Medicare

3 Radiology doctors found. Showing 1 - 3

Justin Bigger, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 132 Abigail Ln, Port Matilda, PA 16870 Phone: 814-272-7100    Fax: 814-272-6501

Allen Wolfe, M.D. Radiology - Neuroradiology Medicare: Accepting Medicare Assignments Practice Location: 132 Abigail Ln, Port Matilda, PA 16870 Phone: 814-272-7100    Fax: 814-272-6501

Usha V Kanakamedala, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 132 Abigail Lane, Port Matilda, PA 16870 Phone: 814-272-7100

News Archive

Contract research organization signs agreement to utilize NewCardio's QTinno(TM) software suite

NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic and services company, today announced that a top-three contract research organization has signed a Master Services Agreement (MSA) to use NewCardio's QTinno(TM) software suite as its technology in fully automated Thorough QT (TQT) and Phase 1 studies delivered by its centralized ECG core lab.

Gene-based method for selecting doses of warfarin no better than standardized dosing methods

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has determined that a gene-based method for selecting patients' doses of the popular heart medication warfarin is no better than standardized dosing methods. The study was presented today at the 2013 Scientific Sessions of the American Heart Association and published simultaneously in the New England Journal of Medicine.

Study looks at attention abilities of babies born through caesarean sections

Being delivered through a caesarean section influences at least one form of babies' ability to concentrate. It slows their spatial attention, which plays a role in how well they are able to prioritize and focus on a particular area or object that is of interest. These are the findings of Scott Adler and Audrey Wong-Kee-You of York University in Canada, published in Springer's journal Attention, Perception, & Psychophysics.

Encouraging results from Gilead's TAF Phase 2 trial on HIV-1 infection

Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.

Read more Medical News

› Verified 4 days ago